Cross-Sector entity
Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention DIAGNOS Inc., the most common co-covered peer. We currently track 1 Cross-Sector story that mention CARA, all published on February 26, 2026.
1 verified story tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention DIAGNOS Inc., the most common co-covered peer. We currently track 1 Cross-Sector story that mention CARA, all published on February 26, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering CARA. Shared-story counts are live from our verified record — not editorial picks.
Market Reporting
Financial news outlets and analysts begin reporting on the company's performance.
Earnings Release
DIAGNOS Inc. issues financial results for the latest fiscal period.
Strategic Expansion
Ongoing rollout of the CARA platform in international markets including Saudi Arabia and Mexico.
DIAGNOS Inc. (OTCMKTS: DGNOF) has released its latest financial results, highlighting the company's ongoing efforts to scale its AI-driven retinal screening platform. The results come as the healthcare industry increasingly adopts automated diagnostic tools to address the global rise in diabetic retinopathy and other vision-threatening conditions.
Source: themarketsdaily.com · tickerreport.com
